申请人:BASF Aktiengesellschaft
公开号:US06136986A1
公开(公告)日:2000-10-24
The invention relates to a process for preparing substituted chroman derivatives of the general formula VII, ##STR1## where X is the group --CN, --COOR.sup.3, --CHO, --CH.sub.2 OR.sup.7 or --CH(OR.sup.8).sub.2, R.sup.2 is a C.sub.1 -C.sub.23 -alkyl, C.sub.2 -C.sub.23 -alkenyl, C.sub.6 -C.sub.18 -aryl or C.sub.7 -C.sub.18 -aralkyl radical, R.sup.3 is hydrogen or an optionally substituted C.sub.1 -C.sub.4 -alkyl radical, R.sup.4, R.sup.5, R.sup.6 are, independently of one another, hydrogen or a C.sub.1 -C.sub.4 -alkyl radical, R.sup.7 is hydrogen or a C.sub.1 -C.sub.4 -alkyl radical, R.sup.8 is a C.sub.1 -C.sub.4 -alkyl radical, or the two radicals are a C.sub.2 -C.sub.6 -alkylene radical which links the two oxygen atoms to form a cyclic acetal and is optionally branched or may carry one or two carboxyl groups, cyclohexyl or phenyl radicals, and to the novel intermediates of the process.
该发明涉及制备通式VII的取代色苷衍生物的过程,其中X是基团--CN,--COOR.sup.3,--CHO,--CH.sub.2 OR.sup.7或--CH(OR.sup.8).sub.2,R.sup.2是C.sub.1-C.sub.23-烷基,C.sub.2-C.sub.23-烯基,C.sub.6-C.sub.18-芳基或C.sub.7-C.sub.18-芳基烷基基团,R.sup.3是氢或可选择取代的C.sub.1-C.sub.4-烷基基团,R.sup.4,R.sup.5,R.sup.6是独立的氢或C.sub.1-C.sub.4-烷基基团,R.sup.7是氢或C.sub.1-C.sub.4-烷基基团,R.sup.8是C.sub.1-C.sub.4-烷基基团,或两个基团是将两个氧原子连接起来形成环状缩醛的C.sub.2-C.sub.6-烷基基团,可选择支链或带有一个或两个羧基,环己基或苯基基团,并涉及该过程的新中间体。